On the fourth day of our festive campaign, we shine a light on the TetraVecta™ system—our 𝟰𝘁𝗵-generation lentiviral vector delivery system. This next-generation innovation can significantly enhance the development and manufacturing of safer and more effective lentiviral vector-based therapies through improved quality, potency and packaging capacity. View our latest TetraVecta™ System poster to discover how this new technology is paving the way for genuine plug and play manufacturing: https://lnkd.in/ep53JA_H Join us tomorrow for day 5! #OXB12Days #LentiviralVectors #ViralVectors #Innovation #CellAndGeneTherapy
Oxford Biomedica’s Post
More Relevant Posts
-
Tomorrow’s webinar will delve into #viralvector production for #cell and #genetherapies, tackling technical and regulatory challenges with insights from Samira Shore, Anne Gilbert, and Jesse Bishop. Specifically, the event will cover facility design, process optimization, and regulatory navigation, offering strategies to streamline approval processes and advance #cell and #genetherapies from bench to bedside. Key takeaways will include: • Gain an understanding of #viralvector production intricacies and process optimization strategies • Learn considerations for facility design and process efficiency in #viralvector therapy production • Obtain insights into regulatory navigation and compliance, including advice on approvals • Benefit from #casestudies showcasing challenges and solutions in viral vector production Register here: http://spr.ly/60435aHV3
To view or add a comment, sign in
-
Did you know Sartobind®️ Rapid A Lab can be reliably reused up to 100 times, minimizing waste and costs? Sartobind®️ Rapid A Lab is an affinity capture unit designed to solve common purification challenges, providing a reliable and efficient option for research scientists who need to purify antibodies and related molecules. 🟨 Plug and Play: Ready-for-use, eliminating setup steps to streamline your workflow. 🟨 Faster: Rapid antibody purification, reducing process time and effort. 🟨 Reusable: Reliably purify over 100 cycles, minimizing consumable costs and waste. Learn more: https://ow.ly/ylL550U91I1 #AntibodyPurification #Sartorius #affinity #Chromatography
To view or add a comment, sign in
-
When performing immunoassays, each washing or transfer step could introduce an error, and these accumulate with every subsequent step. Lumit®️ Immunoassays have a simple, no wash, no transfer protocol resulting in more reliable data with less hands-on time. Find out more ➡️ https://bit.ly/3LPWXaY #Lumit #Immunoassays
To view or add a comment, sign in
-
🩸 From the AABB Annual Meeting's show floor, Terumo Blood and Cell Technologies' Chetan Makam introduces the Reveos® Automated Blood Processing System to IBTV as a disruptive technology, explaining how this technology contributes to addressing the platelet shortage. Chetan goes on to discuss further challenges associated with blood processing, including operational efficiencies, donor issues as well as attracting and retaining the right talent. ▶ Watch the full Movers & Shakers series from AABB, here: https://lnkd.in/edkPYdep #AABB #AABB24 #BloodIsAnEssentialMedicine #ImportanceOfBlood #BloodProcessing #BloodDonation
To view or add a comment, sign in
-
When performing immunoassays, each washing or transfer step will introduce an error, these accumulate with every subsequent step. Lumit Immunoassays have a simple, no wash, no transfer protocol giving you more reliable data with less hands-on time. Find out more here: https://bit.ly/4cBTqsj #HTS #Lumit #Immunoassays
To view or add a comment, sign in
-
When performing immunoassays, each washing or transfer step will introduce an error, these accumulate with every subsequent step. Lumit Immunoassays have a simple, no wash, no transfer protocol giving you more reliable data with less hands-on time. Find out more here: https://bit.ly/46HBtHb #HTS #Lumit #Immunoassays
To view or add a comment, sign in
-
Recently, Pluslife Mini Dock RHAM technology has demonstrated exceptional diagnostic accuracy in an independent evaluation study published in the journal, Scientific Reports. The results showed that Pluslife MiniDock achieved a Positive Percent Agreement (PPA) of 99.00%, comparable to Abbott ID Now's 100.00%, and Cepheid GeneXpert's 98.99%. In terms of Negative Percent Agreement (NPA), Pluslife Mini Dock outperformed the other technologies with a perfect score of 100.00%. Read more at https://lnkd.in/g89YzVqX #Pluslife #moleculardiagnostics #pointofcaretesting #covid19 #infectiousdiseases
To view or add a comment, sign in
-
Pluslife's innovative Mini Dock RHAM technology has showcased remarkable diagnostic accuracy in an evaluation study. Collaborating with the Pfützner Science & Health Institute, Charité - Universitätsmedizin Berlin, DHS - Diagnostic HealthCare Solutions GmbH in Germany, and the University for Digital Technologies in Medicine and Dentistry in Luxembourg, Pluslife has achieved outstanding results, now published in the Scientific Reports journal. In this comparative study against other major point-of-care (POC) testing devices, Pluslife Mini Dock achieved: · Positive Percent Agreement (PPA) of 99.00% (comparable to Abbott ID Now's 100.00% and Cepheid GeneXpert's 98.99%) · Negative Percent Agreement (NPA) of 100.00% (outperforming both Abbott ID Now and Cepheid GeneXpert IV) #HealthcareInnovation #Diagnostics #PointOfCareTesting #RHAMTechnology #QimingPortfolio #QimingHealthcare
Recently, Pluslife Mini Dock RHAM technology has demonstrated exceptional diagnostic accuracy in an independent evaluation study published in the journal, Scientific Reports. The results showed that Pluslife MiniDock achieved a Positive Percent Agreement (PPA) of 99.00%, comparable to Abbott ID Now's 100.00%, and Cepheid GeneXpert's 98.99%. In terms of Negative Percent Agreement (NPA), Pluslife Mini Dock outperformed the other technologies with a perfect score of 100.00%. Read more at https://lnkd.in/g89YzVqX #Pluslife #moleculardiagnostics #pointofcaretesting #covid19 #infectiousdiseases
To view or add a comment, sign in
-
Revive™ is here to set a new standard in regenerative medicine by streamlining the isolation of therapeutic cells from adipose tissue. Our automated, centrifuge-free system tackles the usual challenges of adipose tissue processing, eliminating complexity, minimizing training, and reducing risks of clogging and contamination. Key Features: 1. Automated and Attractive: Enjoy fully automated operation post-setup with a visually appealing design suitable for clinical settings. 2. Time and Cost Efficient: Complete cell isolation in under 90 minutes, allowing your team to focus on other critical tasks. 3. Versatile Applications: Ideal for both treatment and ATMP production, providing a potent mix of mesenchymal stromal cells, regulatory T cells, endothelial progenitors, and pericytes. Revive™ is not just functionally innovative but also user-friendly, offering "plug and play" simplicity that drastically reduces operational complexity and training requirements. #ReviveRegeneration #RegenerativeMedicine #CellTherapy #BiotechInnovation #AutomatedIsolation #ClinicalExcellence #StemCells #AdiposeTissueProcessing
To view or add a comment, sign in
-
Will you be there? Attending the PEGS conference in Boston next week? ✨ Connect with me and the Lonza team at Poster Presentation #C048 to learn about our newest media, the TheraPRO® CHO media system. Tailored for CHOK1 GS-KO® cell lines, our solution simplifies the process while maximizing productivity. If you can't make it to the poster session, contact me to schedule an individual meeting to discuss how TheraPRO® can meet your needs. See you there! #PEGSummit #TheraPROCHO #Lonza #Bioprocessing
To view or add a comment, sign in
41,032 followers